About cookies on this site Our websites require some cookies to function properly (required). In addition, other cookies may be used with your consent to analyze site usage, improve the user experience and for advertising. For more information, please review your options. By visiting our website, you agree to our processing of information as described in IBM’sprivacy statement. To provide a smooth navigation, your cookie preferences will be shared across the IBM web domains listed here.
Publication
Scientific Reports
Paper
Non-destructive inhibition of metallofullerenol Gd@C82(OH) 22 on WW domain: Implication on signal transduction pathway
Abstract
Endohedral metallofullerenol Gd@C82(OH)22 has recently been shown to effectively inhibit tumor growth; however, its potential adverse bioeffects remain to be understood before its wider applications. Here, we present our study on the interaction between Gd@C82(OH) 22 and WW domain, a representative protein domain involved in signaling and regulatory pathway, using all-atom explicit solvent molecular dynamics simulations. We find that Gd@C82(OH)22 has an intrinsic binding preference to the binding groove, particularly the key signature residues Y28 and W39. In its binding competition with the native ligand PRM, Gd@C82(OH)22 is shown to easily win the competition over PRM in occupying the active site, implying that Gd@C 82(OH)22 can impose a potential inhibitory effect on the WW domain. Further analyses with binding free energy landscapes reveal that Gd@C82(OH)22 can not only directly block the binding site of the WW domain, but also effectively distract the PRM from its native binding pocket.